Condition

Pharmacokinetics

ClinicalTrials.gov condition label

Clinical trials36

Recruiting0

Common interventions25

Lead sponsors shown15

Clinical trials

36 shown

Tenofovir Exposures in Advanced Kidney Disease StudyNCT07812571 · 2026-11-01

NOT_YET_RECRUITING

A Clinical Study With Adalimumab BiosimilarNCT06291948 · 2022-08-01

Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740NCT05437094 · 2022-06-27

PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and LevonorgestrelNCT05041699 · 2022-06-20

Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese PatientsNCT05328778 · 2022-04-14

Naldebain for Pain Control After Bariatric SurgeryNCT04651361 · 2021-06-24

Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA PatientsNCT05172817 · 2021-06-02

Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy IndividualsNCT04207840 · 2019-12-09

Pharmacokinetics and Pharmacodynamics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular BlockadeNCT04131218 · 2019-07-16

Itraconazole Pharmacokinetic With and Without Efavirenz Using the Capsule Formulation as Part of Talaromycosis Treatment in HIV-infected AdultsNCT04031053 · 2019-06-01

A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With DiabetesNCT05353686 · 2019-02-25

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of EmpagliflozinNCT03895229 · 2018-10-01

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsNCT03629067 · 2018-09-13

Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)NCT03396445 · 2018-02-18

Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) ChemotherapyNCT03135951 · 2017-05-11

Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusNCT03083782 · 2017-04-18

Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe SubstrateNCT02671097 · 2016-02-01

A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.NCT02512575 · 2015-11-18

Expanded Use PK of Dapivirine Vaginal RingNCT01952561 · 2013-11-01

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart FailureNCT01786512 · 2013-02-26

TAK-875 Glimepiride Drug-Interaction StudyNCT01496443 · 2012-01-01

Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsNCT01309854 · 2011-03-01

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesNCT01226316 · 2010-12-01

Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim ConcentrationsNCT01167452 · 2010-07-01

TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.NCT00828815 · 2009-03-01

TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet FormulationNCT00812292 · 2009-01-01

Variation in Serum Levels of Metformin in Patients With Reduced Renal FunctionNCT00767351 · 2008-10-01

Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women.NCT00746499 · 2008-09-01

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the SkeletonNCT00748046 · 2008-08-01

Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®NCT00710606 · 2008-06-01

Antiretroviral Drug Levels During and After PregnancyNCT00616252 · 2008-02-01

Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex®NCT00532012 · 2007-09-01

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV MedicationNCT00482963 · 2007-05-01

A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body WeightsNCT00298857 · 2006-03-01

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor KaletraNCT00176033 · 2005-01-01

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung SurgeryNCT00644176 · 2004-11-01

Common interventions

Leading sponsors

AstraZeneca3 Bayer2 Guangzhou General Hospital of Guangzhou Military Command2 International Partnership for Microbicides, Inc.2 Tibotec Pharmaceuticals, Ireland2 Ain Shams University1 Amphastar Pharmaceuticals, Inc.1 Boryung Pharmaceutical Co., Ltd1 Cardurion Pharmaceuticals, Inc.1 Chiang Mai University1 Columbia University1 Cytokinetics1 E-DA Hospital1 Heidelberg University1 Institute for Developing Science and Health Initiatives, Bangladesh1

Trial status mix

COMPLETED30

UNKNOWN4

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

PHASE120

PHASE25

PHASE45

PHASE32

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.